Patients with non-small cell lung cancer (NSCLC) require careful staging at the time of diagnosis to determine prognosis and guide treatment recommendations. The seventh edition of the TNM Classification of Malignant Tumors is scheduled to be published in 2009 and the International Association for the Study of Lung Cancer (IASLC) created the Lung Cancer Staging Project (LCSP) to guide revisions to the current lung cancer staging system. These recommendations will be submitted to the American Joint Committee on Cancer (AJCC) and to the Union Internationale Contre le Cancer (UICC) for consideration in the upcoming edition of the staging manual. Data from over 100,000 patients with lung cancer were submitted for analysis and several modificati...
Staging of non-small lung cancer (NSCLC) uses the TNM classification and is undertaken to identify t...
INTRODUCTION: Revisions to the TNM stage classifications for lung cancer, informed by the internatio...
International audiencePURPOSE: To analyze all nonlymphatic metastatic components (T4 and M1) of the ...
International Staging Committee and Participating Institutions Introduction: The seventh edition of ...
International Staging Committee and Participating Institutions Introduction: The seventh edition of ...
Summary: Lung cancer is among the most common type of cancers and is a leading cause of cancer-relat...
SummaryLung cancer remains the most common cause of cancer-related mortality in Scotland, accounting...
of Lung Cancer (IASLC) launched a worldwide TNM staging project to inform the next edition (seventh)...
International audienceOBJECTIVE: In the 2003 Supplement for tumor, node, metastasis (TNM) Staging cl...
The currently adopted staging system for lung cancer is the seventh edition of the TNM staging edite...
Small cell lung cancer (SCLC) is commonly classified as either limited or extensive, but the Union f...
International audienceOBJECTIVE: In the 2003 Supplement for tumor, node, metastasis (TNM) Staging cl...
International audienceOBJECTIVE: In the 2003 Supplement for tumor, node, metastasis (TNM) Staging cl...
Staging is an essential part of the approach to patients with lung cancer. The primary goal of the t...
The tumor, node, metastasis system for cancer staging evolved in the middle of the last century. It ...
Staging of non-small lung cancer (NSCLC) uses the TNM classification and is undertaken to identify t...
INTRODUCTION: Revisions to the TNM stage classifications for lung cancer, informed by the internatio...
International audiencePURPOSE: To analyze all nonlymphatic metastatic components (T4 and M1) of the ...
International Staging Committee and Participating Institutions Introduction: The seventh edition of ...
International Staging Committee and Participating Institutions Introduction: The seventh edition of ...
Summary: Lung cancer is among the most common type of cancers and is a leading cause of cancer-relat...
SummaryLung cancer remains the most common cause of cancer-related mortality in Scotland, accounting...
of Lung Cancer (IASLC) launched a worldwide TNM staging project to inform the next edition (seventh)...
International audienceOBJECTIVE: In the 2003 Supplement for tumor, node, metastasis (TNM) Staging cl...
The currently adopted staging system for lung cancer is the seventh edition of the TNM staging edite...
Small cell lung cancer (SCLC) is commonly classified as either limited or extensive, but the Union f...
International audienceOBJECTIVE: In the 2003 Supplement for tumor, node, metastasis (TNM) Staging cl...
International audienceOBJECTIVE: In the 2003 Supplement for tumor, node, metastasis (TNM) Staging cl...
Staging is an essential part of the approach to patients with lung cancer. The primary goal of the t...
The tumor, node, metastasis system for cancer staging evolved in the middle of the last century. It ...
Staging of non-small lung cancer (NSCLC) uses the TNM classification and is undertaken to identify t...
INTRODUCTION: Revisions to the TNM stage classifications for lung cancer, informed by the internatio...
International audiencePURPOSE: To analyze all nonlymphatic metastatic components (T4 and M1) of the ...